CompletedPhase 3

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation

Germany126 participantsStarted 2008-03

Plain-language summary

Efficacy and Safety from a high-dosed sublingual grass pollen preparation

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Allergic rhinoconjunctivitis attributable to grass pollen * Positive SPT * Positive EAST * Positive provocation Test Exclusion Criteria: * Serious chronic disease * other perennial allergies

What they're measuring

Symptom and Medication Score

Timeframe: Grass pollen season 2009

Trial details

NCT IDNCT00623701

SponsorAllergopharma GmbH & Co. KG

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-10

View on ClinicalTrials.gov More Allergy trials